IGFBP5 and systemic sclerosis: We previously demonstrated that IGFBP-5 was overexpressed in dermal fibroblasts from patients with SSc and pulmonary fibroblasts from patients with IPF and triggered a fibrotic phenotype in vitro in primary human pulmonary fibroblasts [7,8].